Dumont-UCLA Transplant Center, Dumont-UCLA Liver Cancer Center, and Pfleger Liver Institute Present
C
H
A
I
R
Sammy Saab, MD, MPH, AGAF, FACG, FAASLD
Professor of Medicine and Surgery
David Geffen School of Medicine at UCLA
Medical Director, Pfleger Liver Institute
Medical Director, Adult Liver Transplant Program
Chief, Transplant Hepatology
Head, Outcomes Research in Hepatology
Adjunct Professor of Nursing
Fady M. Kaldas, MD, FACS
Professor of Surgery
David Geffen School of Medicine at UCLA
Kelly Lee Tarantello Chair in Liver Transplantation
Director, Multi-Organ Transplantation Fellowship Program
Director, Liver Transplant Service
Co-Director, Heart-Liver Disease Program
C
O
-
C
H
A
I
R
The 18th Annual UCLA Liver Diseases Symposium will provide a state-of-the-art update and scientific exchange on prevalent liver diseases and their complications using a multi-disciplinary approach with hepatologists, radiologists, addiction medicine, and surgeons. With an anticipated attendance of over 100 healthcare professionals, the conference promises an engaging and impactful experience.
Agenda
7:15 – 8:00 AM
Registration, Breakfast & Exhibits
7:15 – 8:00 AM
Industry-Sponsored Event
8:00 – 8:30 AM
Espresso Networking Reception (Exhibit Hall)
8:30 – 8:40 AM
Welcome & Housekeeping
Samer Ebaid, MD, PhD
8:40 – 9:05 AM
Risk Stratification in Chronic Liver Disease Before Elective Surgery
Shaun Chandna, DO
9:05 – 9:30 AM
When to Refer for Liver Transplantation in 2025
Fady Kaldas, MD
9:30 – 9:55 AM
Liver Transplant Extended: Colorectal Metastasis and Cholangiocarcinoma
Vatche Agopian, MD
9:55 – 10:30 AM
Panel Discussion
Patient Selection Committee – Assessing Transplant Candidacy in Patients with Alcohol-Related Liver Disease and Beyond
Akshay Shetty, MD, Katherine Meneses, DNP, FNP-BC, and Julio Meza, MD
10:30 – 10:45 AM
Break/Visit Exhibits
10:45 – 11:10 AM
Treating Refractory PBC and AIH in 2025
Gina Choi, MD
11:10 – 11:35 AM
Emerging Indications for TIPS in Patients with Advanced Liver Disease
Edward W. Lee, MD, PhD
11:35 AM – 12:10 PM
Panel Discussion
Hepatobiliary Tumor Board: Diagnosis and Management of Hepatocellular Carcinoma
Vatche Agopian, MD, Sentia Iriana, MD, MS, and Eward W. Lee, MD, PhD
12:10 – 12:40 PM
Lunch/Visit Exhibits
12:40 – 1:25 PM
Industry-Sponsored Event
1:25 – 1:55 PM
Break/Visit Exhibits
1:55 – 2:20 PM
Artificial Intelligence and Its Current Applications in Hepatology
Jason Pan, MD
2:20 – 2:45 PM
What’s New in Viral Hepatitis B and C
Beshoy Yanny, MD
2:45 – 3:10 PM
Best Practices in Managing Patients with Advanced Fibrosis and Cirrhosis: Update for Clinicians
Jasleen Singh, MD
3:10 – 3:25 PM
Break
3:25 – 4:00 PM
Panel Discussion
Managing Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Multidisciplinary Approach
Mopelola Adeyemo, MD, PhD, Sherona Bau, ACNP, MSN, and Sammy Saab, MD, MPH
4:00 – 4:25 PM
Current and Near-Future Treatments for MASH
Sammy Saab, MD, MPH
4:25 – 4:40 PM
Summary and Closing Remarks
4:40 PM
Adjourn